Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Piccirilli

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD CharacteristicsDavide Carcione, Gioconda Brigante, Antonella Carducci, et al.
Journal of Medical Virology|December 14, 2022
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIVLetizia Santinelli, Giacomo Rossi, Giorgia Gioacchini, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from ItalyBernardetta Segatore, Alessandra Piccirilli, Sabrina Cherubini, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD CharacteristicsDavide Carcione, Gioconda Brigante, Antonella Carducci, et al.
Journal of Medical Virology|December 14, 2022
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIVLetizia Santinelli, Giacomo Rossi, Giorgia Gioacchini, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from ItalyBernardetta Segatore, Alessandra Piccirilli, Sabrina Cherubini, et al.
Pageof 5